Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
365.10    -2.30 (-0.63%)
Bid:
366.50
Ask:
366.80
Spread: 0.30 (0.082%)
Market Cap: £7.50b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Directorate Change

10 Jan 2018 09:33

RNS Number : 4754B
Marks & Spencer Group PLC
10 January 2018
 

 

 

 

Issued: Wednesday 10 January 2018

 

Press Release

Marks and Spencer Group plc appoints Chief Finance Officer

 

Marks and Spencer Group plc (M&S) announces the appointment of Humphrey Singer to its Board as Chief Finance Officer. Humphrey, who is currently Group Finance Director at Dixons Carphone plc, will take up his appointment on a date to be confirmed.

 

Humphrey has been Group FD of Dixons Carphone plc since 2014 following the merger of Dixons Retail with Carphone Warehouse Group. He became Group Finance Director of Dixons in 2011, having held several other finance roles since joining the company in 2007. Humphrey's early career included finance roles at Cadbury Schweppes plc and Coca-Cola Enterprises UK Limited. Humphrey is a Non-Executive Director at Taylor Wimpey plc.

 

Steve Rowe, Chief Executive, M&S, said: "As we embark on our five-year transformation programme, Humphrey will be a great addition to the top team. His experience as part of the team that led Dixons through its period of change and migration to multi-channel retailer is most relevant to what we are undertaking here. This, coupled with his retail expertise and eye for detail and cost, will be very important to our team dynamic as we move forward."

 

Humphrey Singer said: "Under Steve M&S is changing and there's no better time to be joining the team that is transforming the business."

 

Humphrey will replace Helen Weir who, as previously announced, is leaving M&S to pursue a portfolio career. Today her leaving date is confirmed as 31st March 2018.

 

Steve Rowe added: "I'd like to take this opportunity to thank Helen for her significant contribution to M&S over the last three years and wish her all the very best for the future."

 

-Ends-

 

 

 

For further information, please contact:

 

 

Enquiries:

Media +44 (0) 208 718 1919

Investor Relations +44 (0) 203 884 70 80

 

 

Notes to Editors:

Remuneration

 

The following information is provided in accordance with section 430(2B) of the Companies Act 2006:

 

Humphrey Singer

 

· On appointment Humphrey will receive an annual salary of £600,000 with no further fixed-pay cash benefits or allowances.

· In accordance with M&S' remuneration policy, he will be eligible to participate in the Annual Bonus Scheme and Performance Share Plan in line with his start date.

 

Helen Weir

 

· Helen Weir's remuneration terms will be in line with her service agreement and the relevant provisions of the Marks and Spencer Group plc's Executive Remuneration Policy approved by shareholders in 2017.

· Helen Weir will continue in her role until 31 March 2018 and, in line with her service agreement, she will receive salary and benefits, including pension, by way of phased monthly payments (subject to mitigation) from 1 April until 8 November 2018, reflecting the remaining period of contractual notice.

· Helen Weir will remain eligible for consideration for payment of an annual bonus for 2017/18, subject to performance.

· Any unvested nil-cost options awarded to Helen Weir under the Deferred Share Bonus Plan will vest in full on termination and may then be exercised in accordance with the Plan rules.

· Any unvested nil-cost options awarded in 2015 and 2016 under the Performance Share Plan will be time pro-rated and will vest, subject to performance conditions on a wait and see basis at the normal vesting date and may then be exercised in accordance with the Plan rules. The award made in 2017 will lapse on leaving in accordance with the Plan rules.

 

Further details of the operation of the Deferred Share Bonus Plan and Performance Share Plan are set out in the Directors' Remuneration Report in our Annual Report and Financial Statements 2017. Full disclosure of these remuneration arrangements will be provided in our Directors' Remuneration Report in 2018.

 

 

- Ends -

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMMLGZGRZG
Date   Source Headline
1st Jun 202610:00 amRNSAnnual Financial Report
1st Jun 20269:00 amRNSIssue of Shares and Total Voting Rights
28th May 20264:23 pmRNSLichfield Fulfilment Centre Disposal Completion
28th May 20262:12 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
20th May 202610:30 amRNSDirectorate change
20th May 20267:00 amRNSFinal Results
1st May 20269:00 amRNSIssue of Shares and Total Voting Rights
28th Apr 20262:57 pmRNSDirector/PDMR Shareholding
28th Apr 202610:40 amRNSHolding(s) in Company
1st Apr 20269:00 amRNSIssue of Shares and Total Voting Rights
30th Mar 20262:07 pmRNSDirector/PDMR Shareholding
24th Mar 202610:35 amRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20261:00 pmRNSIssue of Shares and Total Voting Rights
19th Feb 20269:38 amRNSHolding(s) in Company
17th Feb 20263:23 pmRNSDirector/PDMR Shareholding
5th Feb 202611:48 amRNSDirector Declaration
3rd Feb 20269:57 amRNSDirector/PDMR Shareholding
2nd Feb 20269:00 amRNSTotal Voting Rights
29th Jan 202610:18 amRNSHolding(s) in Company
28th Jan 202610:42 amRNSDirector/PDMR Shareholding
12th Jan 20264:38 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSChristmas Trading Results
2nd Jan 20269:00 amRNSBlock listing Interim Review
2nd Jan 20269:00 amRNSTotal Voting Rights
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
11th Dec 202510:00 amRNS2025 PSP Award Targets
10th Dec 202510:39 amRNSDirector/PDMR Shareholding
3rd Dec 20254:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20251:43 pmRNSDirector/PDMR Shareholding
1st Dec 20255:34 pmRNSDirector/PDMR Shareholding
1st Dec 20259:00 amRNSTotal Voting Rights
28th Nov 202512:55 pmRNSDirector/PDMR Shareholding
17th Nov 20259:00 amRNSDirectorate change
12th Nov 20255:11 pmRNSDirector/PDMR Shareholding
12th Nov 20259:00 amRNSDirectorate change
11th Nov 202512:00 pmRNSInvestor Presentation
5th Nov 20257:00 amRNSHalf-year Financial Report
3rd Nov 20259:00 amRNSTotal Voting Rights
30th Oct 202510:00 amRNSDirectorate Change
28th Oct 20254:56 pmRNSDirector/PDMR Shareholding
14th Oct 202510:00 amRNSMarks and Spencer Chairmanship
1st Oct 20259:00 amRNSTotal Voting Rights
30th Sep 202511:36 amRNSDirector/PDMR Shareholding
1st Sep 20259:00 amRNSTotal Voting Rights
28th Aug 20252:23 pmRNSDirector/PDMR Shareholding
20th Aug 20259:30 amRNSDirectorate Change
1st Aug 20259:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.